Beginning Nov. 6, Vanderbilt’s Department of Otolaryngology will host a monthly support group for patients living with Ménière’s disease, a disorder effecting the inner ear that is characterized by episodes of symptoms such as vertigo (dizziness), tinnitus (a ringing inside the ear) and hearing loss.

Reyna Gordon, PhD, assistant professor of Otolaryngology and director of the Music Cognition Lab in the Department of Otolaryngology at Vanderbilt University Medical Center, has received a National Institutes of Health (NIH) Director’s New Innovator Award of $2.3 million in total costs for her project, “Biomarkers of Rhythmic Communication: Integrating Foundational and Translational Approaches.”

Surgeons face a delicate proposition when treating acoustic neuromas, benign tumors on the nerve that affect hearing and balance. Removing small tumors through surgery and radiation can cause complications such as the loss of hearing, when the tumors may not grow and impact quality of life for years. But not removing them can allow them to grow and be more difficult to remove and pose even greater risks.

The National Endowment for the Arts (NEA) has designated the Program for Music, Mind and Society at Vanderbilt as a 2018 National Endowment for the Arts Research Lab for its focus on the arts, health and socio-emotional well-being in families of children with and without autism spectrum disorder.

A patient’s mucus may predict the type of his or her chronic sinusitis, which could help doctors determine whether surgery or medical treatments can produce the best outcomes, according to a recently published Vanderbilt study.

The first annual LaryHacks, a competition to design innovative devices, apps or methods to assist laryngectomy patients who have had their voice boxes removed, has been set for Thursday, April 12, 5 to 8 p.m., in the Wond’ry, 2414 Highland Ave. in the Vanderbilt University Engineering and Science building.

Ron Eavey, MD, Guy M. Maness Professor and chair of Otolaryngology and director of the Vanderbilt Bill Wilkerson Center, far right, testified recently at the Food and Drug Administration in Washington, D.C., along with members of Ear Community.